Napronaaf 500 mg (Tablet)
Unit Price: ৳ 10.35 (3 x 10: ৳ 310.50)
Strip Price: ৳ 103.50
Medicine Details
| Category | Details |
|---|---|
| Generic | Naproxen sodium |
| Company | Naafco pharma ltd |
Product title
- Napronaaf
Pharmacological class
- Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Therapeutic class
- Drugs for Osteoarthritis
- Drugs used for Rheumatoid Arthritis
- Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Indications
- rheumatoid arthritis
- osteoarthritis
- ankylosing spondylitis
- juvenile arthritis
- tendonitis
- bursitis
- acute gout
- primary dysmenorrhea
- pain relief
Mode of action
- blocks COX-1 and COX-2 enzymes
- decreases prostaglandin synthesis
- exerts antipyretic, analgesic, and anti-inflammatory properties
- limits gastrointestinal upset and renal toxicities
Dosage and administration
- oral administration with water
- recommended dosage for adults and children
- enteric-coated tablets and suspension forms available
- specific doses for different indications
Interaction
- interference with ACE inhibitors
- delayed absorption with antacids and sucralfate
- increased adverse effects with aspirin
- reduced natriuretic effect with diuretics
Contraindications
- hypersensitivity to Naproxen
- asthma, urticaria, or allergic-type reactions to aspirin or other NSAIDs
- perioperative pain in the setting of coronary artery bypass graft (CABG) surgery
Side effects
- gastrointestinal effects: heartburn, abdominal pain, nausea, diarrhea
- central nervous system effects: headache, vertigo, drowsiness
- dermatological effects: itching, purpura
- cardiovascular effects: edema, palpitation
- others: visual disturbances, hearing disturbances
Pregnancy and lactation
- potential adverse effects on fetus
- delay in parturition in animals
- excretion in breast milk
- careful evaluation in first and third trimesters
- recommendation to avoid breastfeeding during therapy
Precautions and warnings
- potential renal and hepatic effects
- advisory for patients with impaired renal function
- monitoring of serum creatinine and/or creatinine clearance
- caution in patients with creatinine clearance of less than 20ml/min
- reports of moderate to severe jaundice
Storage conditions
- store below 30°C temperature
- protect from light and moisture
- keep out of the reach of children
Color options
- not applicable
Dimensions
- not applicable
Materials
- not applicable
Technical specifications
- not applicable
Design elements
- not applicable
Usability features
- not applicable
Additional features
- not applicable